Skip to main content
OpenTrials
Completed

NCT Number: NCT05916209

PENG and LFCN Block Versus FIC Block for Multimodal Analgesia After Total Hip Replacement Surgery: a Retrospective Analysis

Background: Optimal pain control with limited muscle weakness is paramount for a swift initiation of physical therapy and ambulation. Fascia iliaca compartment block (FICB) has been recommended since it offers the best pain control with low risk of motor block. Pericapsular nerve group block (PENG) with lateral femoral cutaneous nerve (LFCN) block has been proposed as an effective alternative to FICB that offers similar pain control with a considerably lower risk of motor block. This study aimed to compare the afore mentioned blocks and determine which one yielded the lowest NRS score.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Regional Anesthesia Morbidity Arthropathy of Hip Hip Arthropathy

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ospedale Edoardo Bassini

Cinisello Balsamo, Milano, 20092, Italy

About this study

This single-center, retrospective investigation was conducted at ASST Nord Milano Bassini hospital. The study was approved by the ethics committee "Comitato Etico Milano Area 3". The main outcome of the study was the comparison of postoperative pain at 6, 12 and 24 hours, expressed as NRS (numeric rating scale), between PENG and LCFN . Secondary outcomes included total opioid consumption expressed as milligrams of morphine equivalents (MME), time to first opioid request, time to first postoperative ambulation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • elective total hip replacement surgery for non-traumatic hip disease, age >18 years, complete clinical chart included the type of peripheral nerve block performed, signed consent form for spinal anesthesia and peripheral nerve block.

Exclusion criteria

  • incomplete chart, a peripheral nerve block other than PENG or FIC block was performed

Treatment and study plan

peripheral nerve blocks

Procedure

Peripheral nerve blocks provide intense, site-specific analgesia administring local anesthetics near the nerves.

Primary outcomes

  1. pain control

    Time frame: 6 hours after surgery

    pain assessment with Numeric Rating Scale (NRS): a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable"

  2. pain control

    Time frame: 12 hours after surgery

    pain assessment with Numeric Rating Scale (NRS): a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable"

  3. pain control

    Time frame: 24 hours after surgery

    pain assessment with Numeric Rating Scale (NRS): a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable"

Secondary outcomes

  1. MME of PRN opioid doses

    Time frame: 6 hours after surgery

    we studied the effect of Regional anesthesia on opioid-sparing

  2. MME of PRN opioid doses

    Time frame: 12 hours after surgery

    we studied the effect of Regional anesthesia on opioid-sparing

  3. Morphine Milligram Equivalents (MME) of "pro re nata" (PRN) opioid doses

    Time frame: 24 hours after surgery

    we studied the effect of Regional anesthesia on opioid-sparing

Other outcomes

  1. time to first opioid request

    Time frame: From date of surgery until up to 3 days after

    we studied the effect of Regional anesthesia on opioid-sparing

  2. time to first postoperative ambulation

    Time frame: From date of surgery until up to 100 days after

    we studied the effect or Regional anesthesia on residual paralysis

Sponsors and collaborators

Lead sponsor

Ospedale Edoardo Bassini

Other

Registry information

Official study title

Pericapsular Nerve Group (PENG) Block and Lateral Femoral Cutaneous Nerve (LFCN) Block Versus Fascia Iliaca (FIC) Block for Multimodal Analgesia After Total Hip Replacement Surgery: a Retrospective Analysis

Acronym: PENG+LFCN-FICB

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Jun 23, 2023
Registry last updated
Jun 23, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.